ENVB
NASDAQ · Pharmaceuticals
Enveric Biosciences Inc
$2.85
-0.32 (-10.09%)
Open$3.16
Previous Close$3.17
Day High$3.18
Day Low$2.82
52W High$17.84
52W Low$1.71
Volume—
Avg Volume5.50M
Market Cap6.29M
P/E Ratio—
EPS$-89.80
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+247.7% upside
Current
$2.85
$2.85
Target
$9.91
$9.91
$5.56
$9.91 avg
$13.09
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 6.30B | 6.09B | 1.01M |
| Net Income | -360,399,802 | -313,845,981 | 237.2K |
| Profit Margin | -14.0% | -13.3% | 23.5% |
| EBITDA | -348,182,691 | -320,051,820 | 375.3K |
| Free Cash Flow | — | — | 127.9K |
| Rev Growth | +3.4% | +3.4% | -4.2% |
| Debt/Equity | — | — | 0.59 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |